Results 111 to 120 of about 37,478 (219)

Core–Sheath Nanofibers From a Modified Coaxial Electrospinning for Transdermal Delivery of Finasteride

ChemistryOpen, Volume 15, Issue 6, June 2026.
A modified coaxial electrospinning was conducted to prepare core–sheath nanofibers. They have transdermal enhancer sodium dodecyl sulfate (SDS) and soluble polyvinylpyrrolidone in their sheaths, and finasteride and insoluble ethylcellulose in the cores.
Liang Sun, Yisa Zhao, Xiyu Caomeng, Deng‐Guang Yu, Ping Liu   +4 more
wiley   +1 more source

Systemic Oxidative and Nitrosative Stress in Benign Prostatic Hyperplasia. [PDF]

Antioxidants (Basel)
Biesiadecki M, Galiniak S, Balawender K, Połeć J, Mołoń M.   +4 more
europepmc   +1 more source

A Pilot Study of 18F‐rhPSMA‐7.3‐PET/MRI to Reduce Mischaracterization of Active Surveillance and Focal Therapy Candidates With Occult Higher Risk Disease

The Prostate, Volume 86, Issue 8, Page 865-871, June 2026.
ABSTRACT Introduction PSMA‐PET offers an opportunity to reduce the mischaracterization of disease in active surveillance (AS) and focal therapy (FT) candidates. We describe the results of a pilot clinical trial evaluating 18F‐radiohybrid(rh)PSMA‐7.3‐PET/MRI to detect occult adverse pathology among potential AS and FT candidates (NCT05852041).
Ridwan Alam, Derek Hesse, Nikki Hubbard, Emma McGarrity, Sai Kumar, Clayton Neill, Yutai Li, Nicole Handa, Hiten D. Patel, Edward M. Schaeffer, Hatice Savas, Ashley E. Ross   +11 more
wiley   +1 more source

Artificial Intelligence as a Diagnostic Tool for Benign Prostatic Hyperplasia (BPH): A Narrative Review. [PDF]

Res Rep Urol
Aljazei E.
europepmc   +1 more source

Benign prostatic hyperplasia

BMJ, 1999
openaire   +3 more sources

Treatment of benign prostatic hyperplasia [PDF]

Revista da Associação Médica Brasileira, 2017
Ricardo Vita, Nunes, João, Manzano, José Carlos, Truzzi, Aguinaldo, Nardi, Antonio, Silvinato, Wanderley Marques, Bernardo   +5 more
openaire   +2 more sources

Exploring the Gut‐Prostate Axis: Microbial Signatures Linked to Prostate Volume and Bladder Function

The Prostate, Volume 86, Issue 8, Page 900-910, June 2026.
ABSTRACT Background Benign prostatic hyperplasia (BPH) is a common urologic condition in aging men, often linked to systemic inflammation and metabolic dysfunction. Emerging evidence suggests that the gut microbiome may contribute to prostate health and disease.
Jonathan Surber, Marie Lork, Yasser Morsy, Michael Scharl, Daniel Stephan Engeler, Janine Langenauer, Lukas John Hefermehl, Anna Ebner, Basil Kaufmann, Manuela Hunziker, Daniel Eberli, Uwe Bieri, Cédric Poyet   +12 more
wiley   +1 more source

Curcumin versus placebo in benign prostatic hyperplasia: a systematic review and meta-analysis. [PDF]

Eur J Clin Pharmacol
Santana DS, Porto BC, Cardoso RB, Lopes GMM, Gimenez LGS, Passerotti CC, Maia R, Almeida FG, da Silva Sardenberg RA, da Cruz JAS.   +9 more
europepmc   +1 more source

Awareness and Knowledge of Lower Urinary Tract Symptoms (LUTS) Among Male Adults in Primary Care Settings in Hong Kong: A Questionnaire‐Based Study

Trends in Urology &Men's Health, Volume 17, Issue 3, June 2026.
ABSTRACT This study aims to assess the awareness and knowledge level of lower urinary tract symptoms (LUTS) in male adults in primary care setting in Hong Kong and explore its relationship with the behavior of seeking medical help. This is a cross‐sectional questionnaire‐based study recruited male adults aged 40 years or older.
Lik Tai, Hei Lim Li
wiley   +1 more source

A single cell transcriptional profile of benign prostatic hyperplasia. [PDF]

Sci Rep
Unno R, Akutagawa J, Song H, Hui K, Chen YA, Pham JH, Lee J, Yang H, Huang FW, Chi T.   +9 more
europepmc   +1 more source